Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

Detalles Bibliográficos
Autores principales: Boelaert, Jente, Schepers, Eva, Glorieux, Griet, Eloot, Sunny, Vanholder, Raymond, Lynen, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127109/
https://www.ncbi.nlm.nih.gov/pubmed/27801792
http://dx.doi.org/10.3390/toxins8110312
_version_ 1782470212082204672
author Boelaert, Jente
Schepers, Eva
Glorieux, Griet
Eloot, Sunny
Vanholder, Raymond
Lynen, Frédéric
author_facet Boelaert, Jente
Schepers, Eva
Glorieux, Griet
Eloot, Sunny
Vanholder, Raymond
Lynen, Frédéric
author_sort Boelaert, Jente
collection PubMed
description
format Online
Article
Text
id pubmed-5127109
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51271092016-12-02 Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149 Boelaert, Jente Schepers, Eva Glorieux, Griet Eloot, Sunny Vanholder, Raymond Lynen, Frédéric Toxins (Basel) Reply MDPI 2016-10-27 /pmc/articles/PMC5127109/ /pubmed/27801792 http://dx.doi.org/10.3390/toxins8110312 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Boelaert, Jente
Schepers, Eva
Glorieux, Griet
Eloot, Sunny
Vanholder, Raymond
Lynen, Frédéric
Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_full Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_fullStr Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_full_unstemmed Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_short Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
title_sort response to tsikas et al. comments on boelaert et al. determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: uplc–ms/ms versus elisa. toxins 2016, 8, 149
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127109/
https://www.ncbi.nlm.nih.gov/pubmed/27801792
http://dx.doi.org/10.3390/toxins8110312
work_keys_str_mv AT boelaertjente responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT scheperseva responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT glorieuxgriet responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT elootsunny responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT vanholderraymond responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149
AT lynenfrederic responsetotsikasetalcommentsonboelaertetaldeterminationofasymmetricandsymmetricdimethylarginineinserumfrompatientswithchronickidneydiseaseuplcmsmsversuselisatoxins20168149

Ejemplares similares